Fell almost 20% today!
Anyone live near their Scottish works (or Newcastle upon Tyne region)....can comment on activity, staffing etc?

I wonder what their cash position is, bearing in mind they have floated Nov2005 and already the sp is nearly halved.....oh dear!
Could be lack of news, or....... news that dare not speak its....

Not a holder but interested to learn more, they have a deal with Neuron and some Government body, but this may be short-lived I guess. Based on stem-cell research/production this is a Political area where Public minds can change rapidly.
If it is Gov funding then this can be cut overnight, or something nasty eascapes (or Newspapers say it has escaped, etc)

I note that the spread is a robust 40%, now why is that? (very low volumes?-dunno.)
Anyone holding?

I have shares 4 my sins.Dont know much but have faith n stem cells to hopefully find cures 4 current illness.
I get no annual report notn from abh.l
Directors ye would want 2 buck up its now 2007
Here's 2 a cysmic change 4 the good of Angel Bio n 07
Happy New Year 2 ye all from Ireland

Looks like a good opportunity presenting itself for buyers at the moment.

RNS Number:8073Z
Angel Biotechnology Holdings Plc
06 July 2007




July 6, 2007


ANGEL BIOTECHNOLOGY HOLDINGS PLC
("Angel" or "the Company")

Angel announces GMP Manufacturing contract



Angel Biotechnology Holdings plc, (AIM: ABH) the biopharmaceutical contract
manufacturer, is pleased to announce the signing of a contract with Materia
Medica Holdings, based in Russia. The contract, valued at circa #450,000, is for
process development and GMP manufacture of polyclonal antibodies.



Gordon Sherriff, Chief Operating Officer of Angel Biotechnology Holdings plc,
said: "We are pleased to have this opportunity to work with a leading Russian
pharmaceutical company. We look forward to this contract forming the basis of a
long and fruitful working relationship. Indeed, discussions for a second
contract are at an advanced stage"



Sergey Tarasov, of Materia Medica Holding's R&D department, said: "We are
confident that Angel Biotechnology's GMP certified facilities and their strong,
established management and manufacturing teams will ensure the highest quality
for our products. We hope to build a strong on-going relationship with Angel and
to establish them as our manufacturer for future projects."

For further information, please call:
Angel Biotechnology Holdings plc Tel: +44 (0) 1670 591920
Gordon Sherriff - Chief Operating Officer Tel: +44 (0) 7951 057016

About Angel Biotechnology Holdings plc

Angel Biotechnology Holdings plc is a fast growing biomanufacturing company
offering process development services and cGMP manufacturing to support
biotechnology and pharmaceutical companies worldwide. Angel's principal
activity is the manufacture and supply of materials for use in early stage drug
development and pre-clinical studies, along with drug product and CMC
documentation for Phases I, II and III clinical trials and the manufacture of
licensed drugs or vaccines.



Angel is managed by a team that has more than 100 years' combined experience in
pharmaceutical and biopharmaceutical manufacture, gained in companies such as
Glaxo, SmithKline Beecham and Serologicals Inc.

Angel was established in 2000 and was admitted to trading on AIM in November
2005.

Took a position on these today this will move fast when the second contract comes through.

The biopharmaceutical contract manufacturer said discussions for a second contract with Materia Medica are at an advanced stage.


http://www.angelbio.com/landing.asp?id=2

Who's incharge of investors relations at ABH, seems they stopped caring about the investors when they released share placings notice after the market closed, very sneaky...thought we'd not notice!

166
Still, 70m + trades today punters are still interested.

Right- on Raju16,
Methinks someone knows something more about the second contract......
48,848,817 buys.

The SP does not reflect the true path.

WHO IS BILLIAM AG ? Does anyone know?

'Angel Biotechnology says Billiam holds 3.385 pct stake in co
AFX
LONDON (Thomson Financial) - Angel Biotechnology Holdings PLC said Billiam AG now holds 3.385 pct or about 40.43 mln shares in the company after it purchased 10 mln shares at 0.19 pence apiece.'

It is, as you probably suspect Raju, a misquote. It was correctly quoted on MoneyAM however:-

The Company was informed today that following an acquisition of 10,000,000
ordinary shares of the Company of 0.1p each ('Ordinary Shares') for 0.19p per
share on 20 July 2007, Billam AG now holds 40,428,571 Ordinary Shares
representing 3.385 per cent. of the total voting rights of the Company.

So Billam AG get my vote
as being the correct quote.

There, a bit of rhyming thrown in free!

I spoke to Gordon Sherriff today and was very encouraged. I think they possibly overstretched themselves based on the US contract and hence pushed ahead wih Cramlington. With the US contact not coming to fruition they have restructured, closed Cramlington thus cutting overheads to become a leaner operation again. I suspect they will soon be profitable. As Gordon said he did not buy shares recently at .175p with a view to losing money. I said that I had taken that as a positive sign and he was pleased that it had given reassurance and thanked me for sticking with them. He said they were aware that the current Sp probably reflected the lack of news but they hoped to address that soon.

Certainly worth any other large holders who have concerns contacting them as I found them to be very approachable. It did indeed give reassurance and made me think a positive future lies ahead so added another million this afternoon.

((Gatyenbank your knowledge would appear to have paid off, but from the sidelines - - - - ))
Monday
Very odd sp movement; someone remind me "Bargepoles" should I think of investing. Even with Today's 50% uplift this business has masses of shares on the Market and Billam ( see Investment RNS a while ago) who, presumably, bought cheaply has seen their holding drop in value. =Bad call.
SP movements like today's are Bad News and frankly the RNS (today) about a new certificate of manufacture is hardly earth-shattering - - - wouldn't you expect a new factory (paid for by we punters! Grr). . . would indeed have all the necessary standards?
Of course you would . . . . and the sp should only move barely 5% as the market takes note the Execs haven't (yet) Jetted-off to sunny climes, clutching their bonuses... which will no-doubt require ". . . a strong sp-performance... er, Ho-Ho."
Currently the Mkt Cap is just 1m, so expect some consolidation to remove the paltry sp "value" under 1p.
I suspect that having a Government Customer (the NHS) is seen as a negative, being penny-pinching although reasonably safe, until they find some old pills in a cupboard, or overseas when the Patent runs out.

I should have AV down I'm still on these, nice rise.

+20% this morning with a much needed reduced spread.

RNS confirms the Co is in discussion . . . .

Well, it's nice to know the Execs are awake, even though they took their time to shake the sleep out of their eyes. It is about time Company Execs took care of their responsibilities . . . . not by waiting unil the News is "out" - but well in advance!

Leaves a nasty Whiff, IMHO.

EDIT Oct08 - after slight rise, methinks BargePoles....

Angel Biotechnology Issue of Equity




RNS Number : 4108W
Angel Biotechnology Holdings Plc
11 June 2008


Wednesday 11 June 2008

Angel Biotechnology Holdings plc
("the Company")
Issue of Equity

The Company announces that application has been made for the admission to trading on AIM
of 7,357,142 Ordinary Shares of 0.1p nominal
value. Admission is expected to take place on 13 June 2008.

The shares have been issued following the exercise of warrants at a price of 0.175p per
share.


For further information:

Angel Biotechnology Holdings plc 07747 842446
Dr Paul Harper, Chairman

Grant Thornton Corporate Finance 020 7383 5100
Philip Secrett, Colin Aaronson

I found the original thread. Can't be that hard if I can do it!

? what's wrong with the other thread ?

What next for the SP.... it's been looking strong the past couple of weeks..hopefully it'll continue that way.

Good report and now in profit, with good order book.
Highlights:
Business Highlights for the period are:



The Company made a net profit in H1 2010 of 106,737. We expect this trend to continue and look forward to announcing a net profit for the full year 2010.

Net liabilities have reduced from 1.6m (Dec 09) to 100,000.

Eight new contracts were signed and two contracts were extended in the period, with a total value of more than 3.3m.

More than 92% of 2010 budgeted business has been signed and almost 40% of the business budgeted for 2011.

Three of the new contracts signed were specifically to provide regulatory support.

Successfully raised 1.425m before expenses through Hybridan acting as broker, to provide working capital and to facilitate an expansion of the companies resource

Appointed Lorna Peers as Group Financial Controller and Company Secretary





Gordon Sherriff, COO of Angel Biotechnology Holdings Plc, said:



"Angel has enjoyed a successful and productive first 6 months of 2010. In addition to making our first ever half year profit, we have now secured most of the business required to deliver our plan for 2010.

The business development team continue to secure new business for 2011, currently amounting to almost 40% of our target and we expect to remain profitable in H2 of 2010, to record the first annual profit in our history. This is a remarkable achievement by the Company in a market that remains challenging. This is a testament to the determined efforts of the business development team to secure new business and the operational team to deliver our clients milestones. The Directors are confident that the business has turned an important corner and we expect to be able to build on this success.